Bahrain said it had approved the emergency use of a COVID-19 vaccine developed by Pfizer and German partner BioNTech.
"The approval of the Pfizer/BioNTech vaccine will add a further important layer to the kingdom's national Covid-19 response," said Mariam al-Jalahma, CEO of the National Health Regulatory Authority, according to a statement carried by the official Bahrain News Agency (BNA).
Manama did not specify when it would begin the vaccine's rollout by US pharmaceutical giant Pfizer and its German partner BioNTech.
Britain on Wednesday said it approved the Covid-19 vaccine for general use, with plans to start rolling it out next week.
In November, the small Gulf kingdom of Bahrain approved China's Sinopharm vaccine on frontline healthcare workers.
